Mithra Pharmaceuticals SA (STU:1TM)
€ 0.18 0 (0%) Market Cap: 12.04 Mil Enterprise Value: 196.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation Transcript

Dec 20, 2022 / 08:00AM GMT
Release Date Price: €4 (+5.26%)
Operator

Presentation
Dec 20, 2022 / 08:00AM GMT

=====================
Corporate Participants
=====================
* Benoit Mathieu
Mithra Pharmaceuticals SA - Group IR Manager
* Christophe Marechal
Mithra Pharmaceuticals SA - CFO
* Graham K. Dixon
Mithra Pharmaceuticals SA - Chief Scientific Officer
* Jean-Manuel Fontaine
Mithra Pharmaceuticals SA - Chief Commercial & External Affairs Officer
* Leon Van Rompay
Mithra Pharmaceuticals SA - CEO

=====================
Conference Call Participants
=====================
* Clément Bassat
Portzamparc BNP Paribas Group, Research Division - Financial Analyst
* Laura Roba
Banque Degroof Petercam S.A., Research Division - Analyst
* Thomas Vranken
KBC Securities NV, Research Division - Equity Analyst of Pharma & Biotech

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot